产品纯度高,应用于
E LISA和FACS,做抑制和结合实验,数据结果稳定,几批结果做出的图基本一致,EC50和IC50 几批结果误差很小。
2019-11-27
PD-1 & PD-L1 分子别名
PD-1 & PD-L1
PD-1 & PD-L1 分子背景
Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.